Finemedix Statistics

Total Valuation

Finemedix has a market cap or net worth of KRW 45.67 billion. The enterprise value is 43.38 billion.

Market Cap	45.67B
Enterprise Value	43.38B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Finemedix has 5.43 million shares outstanding. The number of shares has increased by 13.88% in one year.

Current Share Class	5.43M
Shares Outstanding	5.43M
Shares Change (YoY)	+13.88%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	37.29%
Owned by Institutions (%)	n/a
Float	2.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.36
PB Ratio	2.49
P/TBV Ratio	2.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-30.04
EV / Sales	4.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.27

Financial Position

The company has a current ratio of 5.47, with a Debt / Equity ratio of 0.16.

Current Ratio	5.47
Quick Ratio	3.29
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-0.81
Interest Coverage	-18.87

Financial Efficiency

Return on equity (ROE) is -9.54% and return on invested capital (ROIC) is -5.90%.

Return on Equity (ROE)	-9.54%
Return on Assets (ROA)	-5.27%
Return on Invested Capital (ROIC)	-5.90%
Return on Capital Employed (ROCE)	-8.21%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.50
Inventory Turnover	1.26

Taxes

Income Tax	-354.80M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	8,048.60
200-Day Moving Average	8,064.40
Relative Strength Index (RSI)	62.84
Average Volume (20 Days)	28,659

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Finemedix had revenue of KRW 10.48 billion and -1.44 billion in losses. Loss per share was -276.20.

Revenue	10.48B
Gross Profit	5.34B
Operating Income	-1.75B
Pretax Income	-1.80B
Net Income	-1.44B
EBITDA	-775.47M
EBIT	-1.75B
Loss Per Share	-276.20

Full Income Statement

Balance Sheet

The company has 5.15 billion in cash and 2.86 billion in debt, giving a net cash position of 2.29 billion or 422.29 per share.

Cash & Cash Equivalents	5.15B
Total Debt	2.86B
Net Cash	2.29B
Net Cash Per Share	422.29
Equity (Book Value)	18.36B
Book Value Per Share	3,373.78
Working Capital	10.45B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.63 billion and capital expenditures -902.50 million, giving a free cash flow of -3.53 billion.

Operating Cash Flow	-2.63B
Capital Expenditures	-902.50M
Free Cash Flow	-3.53B
FCF Per Share	-650.78

Full Cash Flow Statement

Margins

Gross margin is 50.90%, with operating and profit margins of -16.71% and -13.77%.

Gross Margin	50.90%
Operating Margin	-16.71%
Pretax Margin	-17.16%
Profit Margin	-13.77%
EBITDA Margin	-7.40%
EBIT Margin	-16.71%
FCF Margin	n/a

Dividends & Yields

Finemedix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.88%
Shareholder Yield	-13.88%
Earnings Yield	-3.16%
FCF Yield	-7.74%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Finemedix has an Altman Z-Score of 5.98 and a Piotroski F-Score of 2.

Altman Z-Score	5.98
Piotroski F-Score	2